Search Results
Results found for "Agilent"
- Dr. Peter Robert Banks | Dr. GPCR Ecosystem
Robert Banks Peter Banks is currently the Scientific Director at BioTek Instruments , now a part of Agilent
- Team Access to Terry’s Pharmacology Corner | 25% Group Discount | Dr. GPCR Ecosystem
discovery • Monthly live AMA discussions with Terry Kenakin • Ongoing Terry’s Corner lessons and analysis • Ability
- Signals, pH, and Discovery : Cracking GPCR Mysteries with Dr. Ian Chronis | Dr. GPCR Ecosystem
fascinating findings from his work on GPR65 , highlighting its unusual constitutive internalization and its ability
- Alexander Hauser: GPCR Pharmacogenomics and Precision Psychiatry | Dr. GPCR Ecosystem
pharmacological domain knowledge produces noise, not insight Hauser draws a sharp distinction between the ability to manipulate large datasets and the ability to interpret them.
- Dr. Aurélien Rizk | Dr. GPCR Ecosystem
The conversation also revolved around the company's ability to predict the residence time of a ligand
- Terry Hebert: How Cellular Background and Localization Influence GPCR Function | Dr. GPCR Ecosystem
His favorite GPCR is the angiotensin 1 receptor, especially for its ability to activate a large variety
- Sam Hoare: Receptor Residence Time and GPCR Data Analysis | Dr. GPCR Ecosystem
The ability to serve as a sounding board — to help people relax around their data and see what was obscured
- Pfleger: NanoBRET, Receptor Complexes, and the Translation of GPCR Pharmacology | Dr. GPCR Ecosystem
That will change their ability to bind."
- Graciela Piñeyro: Partial Agonism, Receptor Recycling, and the Limits of Bias | Dr. GPCR Ecosystem
on the molecular pharmacology of opioid receptors, exploring their signaling, trafficking, and their ability
- EARNEST Panel: Can AI Accelerate GPCR Drug Discovery? | Dr. GPCR Ecosystem
techniques in areas such as protein structure prediction, bioactive ligand discovery, in-vivo translation ability
- Michel Bouvier: BRET, Biased Agonism, and the Tools That Changed GPCR Pharmacology | Dr. GPCR Ecosystem
Bouvier’s ability to ask highly relevant questions during meetings.
- Brian Arey: Discovering Signaling Bias at the FSH Receptor | Dr. GPCR Ecosystem
"If you've done all the controls appropriately, and you've done the experiments to the best of your ability
- David Gloriam: Orphan Receptors, GPCRDB, and the Data Revolution in GPCR Pharmacology | Dr. GPCR Ecosystem
interpretation and understanding of the data - because we have so much data now, and it's actually our ability
- Joseph Kim: Structural Biology and Drug Discovery at GPCRs | Dr. GPCR Ecosystem
The discussion explores how structural biology technologies—particularly cryo-EM—have transformed the ability
